However, long-term use of anti-TNFα agents has been associated with the risk of serious infections, malignancies, skin and soft tissue infections, and tuberculosis (Baghai et al., 2001; Kroesen et al., 2003; Colombel et al., 2004). Here, TNF is linked to tuberculosis.